Most protocols balance injection volume against precision, using 1-2ml for most reconstitutions
The Exenatide-PD3 trial , a large phase 3 study, is evaluating whether exenatide can slow Parkinson's disease progression over an extended period
Preparing to inject MOUNJARO Check the vial label to make sure you have the right medicine and dose, and that it has not expired
Important issues to review include nausea, vomiting, constipation, diarrhea, reflux, hydration status, protein intake, muscle preservation, diabetes medications, gallbladder symptoms, kidney function, history of pancreatitis, thyroid and family history considerations, and long-term maintenance strategy